In addition to inhibiting the activation of a series of fibroblasts induced by activated TGF-beta/smad3, cinobufagin can also reduce the source of myofibroblasts by resisting EMT and further improve pulmonary fibrosis. The gene discussed is SMAD3; the disease is pulmonary fibrosis.